In an in vitro 3D model of basal-like breast cancer, use of the RUNX/CBFβ inhibitor was shown to exert a striking growth-inhibitory effect with almost complete suppression of cell survival and colony formation [186]. Here, CBFB is linked to breast carcinoma.